Rapid generation of microRNA sponges for microRNA inhibition

PLoS ONE

Volumn 7, Issue 1, 2012, Pages

  Kluiver, Joost ^a   Gibcus, Johan H ^a   Hettinga, Chris ^a   Adema, Annelies ^a   Richter, Mareike K S ^a   Halsema, Nancy ^a   Slezak Prochazka, Izabella ^a   Ding, Ye ^b   Kroesen, Bart Jan ^a   van den Berg, Anke ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b WADSWORTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; GREEN FLUORESCENT PROTEIN; LUCIFERASE; MICRORNA; COMPLEMENTARY RNA; MIRN19 MICRORNA, HUMAN;

ARTICLE; BINDING SITE; CONTROLLED STUDY; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; INHIBITION KINETICS; LOSS OF FUNCTION MUTATION; MOLECULAR CLONING; PROTEIN DEGRADATION; QUANTITATIVE ANALYSIS; RNA BINDING; ANIMAL; BINDING COMPETITION; CELL STRAIN HEK293; CHEMISTRY; DRUG ANTAGONISM; EVALUATION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; METHODOLOGY; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; RNA INTERFERENCE; SYNTHESIS; TIME; TUMOR CELL CULTURE; VALIDATION STUDY;

ANIMALS; BASE SEQUENCE; BINDING, COMPETITIVE; CLONING, MOLECULAR; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HUMANS; MICRORNAS; RNA INTERFERENCE; RNA, ANTISENSE; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 84855417964     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0029275     Document Type: Article

References (32)

1. Brown BD, Naldini L, (2009) Exploiting and antagonizing microRNA regulation for therapeutic and experimental applications. Nat Rev Genet 10 (8): 578-585.
2. Kloosterman WP, Lagendijk AK, Ketting RF, Moulton JD, Plasterk RH, (2007) Targeted inhibition of miRNA maturation with morpholinos reveals a role for miR-375 in pancreatic islet development. PLoS Biol 5 (8): e203.
3. Krutzfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, et al. (2005) Silencing of microRNAs in vivo with 'antagomirs'. Nature 438 (7068): 685-689.
4. Park CY, Choi YS, McManus MT, (2010) Analysis of microRNA knockouts in mice. Hum Mol Genet 19: R169-R175.
5. Ebert MS, Neilson JR, Sharp PA, (2007) MicroRNA sponges: Competitive inhibitors of small RNAs in mammalian cells. Nat Methods 4 (9): 721-726.
6. Ebert MS, Sharp PA, (2010) MicroRNA sponges: Progress and possibilities. RNA 16 (11): 2043-2050.
7. Papapetrou EP, Korkola JE, Sadelain M, (2010) A genetic strategy for single and combinatorial analysis of miRNA function in mammalian hematopoietic stem cells. Stem Cells 28 (2): 287-296.
8. Kumar MS, Erkeland SJ, Pester RE, Chen CY, Ebert MS, et al. (2008) Suppression of non-small cell lung tumor development by the let-7 microRNA family. Proc Natl Acad Sci U S A 105 (10): 3903-3908.
9. Loya CM, Lu CS, Van Vactor D, Fulga TA, (2009) Transgenic microRNA inhibition with spatiotemporal specificity in intact organisms. Nat Methods 6 (12): 897-903.
10. Gentner B, Schira G, Giustacchini A, Amendola M, Brown BD, et al. (2009) Stable knockdown of microRNA in vivo by lentiviral vectors. Nat Methods 6 (1): 63-66.
11. Haraguchi T, Ozaki Y, Iba H, (2009) Vectors expressing efficient RNA decoys achieve the long-term suppression of specific microRNA activity in mammalian cells. Nucleic Acids Res 37 (6): e43.
12. Hutvagner G, Zamore PD, (2002) A microRNA in a multiple-turnover RNAi enzyme complex. Science 297 (5589): 2056-2060.
13. Liu J, Carmell MA, Rivas FV, Marsden CG, Thomson JM, et al. (2004) Argonaute2 is the catalytic engine of mammalian RNAi. Science 305 (5689): 1437-1441.
14. Care A, Catalucci D, Felicetti F, Bonci D, Addario A, et al. (2007) MicroRNA-133 controls cardiac hypertrophy. Nat Med 13 (5): 613-618.
15. Scherr M, Venturini L, Eder M, (2010) Lentiviral vector-mediated expression of pre-miRNAs and antagomiRs. Methods Mol Biol 614: 175-185.
16. Brown BD, Gentner B, Cantore A, Colleoni S, Amendola M, et al. (2007) Endogenous microRNA can be broadly exploited to regulate transgene expression according to tissue, lineage and differentiation state. Nat Biotechnol 25 (12): 1457-1467.
17. Mukherji S, Ebert MS, Zheng GX, Tsang JS, Sharp PA, et al. (2011) MicroRNAs can generate thresholds in target gene expression. Nat Genet 43 (9): 854-859.
18. Mavrakis KJ, Wolfe AL, Oricchio E, Palomero T, de Keersmaecker K, et al. (2010) Genome-wide RNA-mediated interference screen identifies miR-19 targets in notch-induced T-cell acute lymphoblastic leukaemia. Nat Cell Biol 12 (4): 372-379.
19. Mu P, Han YC, Betel D, Yao E, Squatrito M, et al. (2009) Genetic dissection of the miR-17~92 cluster of microRNAs in myc-induced B-cell lymphomas. Genes Dev 23 (24): 2806-2811.
20. Landthaler M, Gaidatzis D, Rothballer A, Chen PY, Soll SJ, et al. (2008) Molecular characterization of human argonaute-containing ribonucleoprotein complexes and their bound target mRNAs. RNA 14 (12): 2580-2596.
21. He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D, et al. (2005) A microRNA polycistron as a potential human oncogene. Nature 435 (7043): 828-833.
22. O'Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT, (2005) c-myc-regulated microRNAs modulate E2F1 expression. Nature 435 (7043): 839-843.
23. Olive V, Bennett MJ, Walker JC, Ma C, Jiang I, et al. (2009) miR-19 is a key oncogenic component of mir-17-92. Genes Dev 23 (24): 2839-2849.
24. Kluiver J, Poppema S, de Jong D, Blokzijl T, Harms G, et al. (2005) BIC and miR-155 are highly expressed in hodgkin, primary mediastinal and diffuse large B cell lymphomas. J Pathol 207 (2): 243-249.
25. Brown BD, Venneri MA, Zingale A, Sergi LS, Naldini L, (2006) Endogenous microRNA regulation suppresses transgene expression in hematopoietic lineages and enables stable gene transfer. Nat Med 12 (5): 585-591.
26. Kelly EJ, Hadac EM, Greiner S, Russell SJ, (2008) Engineering microRNA responsiveness to decrease virus pathogenicity. Nat Med 14 (11): 1278-1283.
27. Swift S, Lorens J, Achacoso P, Nolan GP, (2001) Rapid production of retroviruses for efficient gene delivery to mammalian cells using 293T cell-based systems. Curr Protoc Immunol Chapter 10: Unit 10.17C.
28. Simcox TG, Fabian L, Kretz K, Hedden V, Simcox ME, (1995) SanDI, a new type-II restriction endonuclease that recognizes 5′-GG/GWCCC-3′. Gene 155 (1): 129-130.
29. Kertesz M, Iovino N, Unnerstall U, Gaul U, Segal E, (2007) The role of site accessibility in microRNA target recognition. Nat Genet 39 (10): 1278-1284.
30. Long D, Lee R, Williams P, Chan CY, Ambros V, et al. (2007) Potent effect of target structure on microRNA function. Nat Struct Mol Biol 14 (4): 287-294.
31. Gibcus JH, Tan LP, Harms G, Schakel RN, de Jong D, et al. (2009) Hodgkin lymphoma cell lines are characterized by a specific miRNA expression profile. Neoplasia 11 (2): 167-176.
32. Tan LP, Seinen E, Duns G, de Jong D, Sibon OC, et al. (2009) A high throughput experimental approach to identify miRNA targets in human cells. Nucleic Acids Res 37 (20): e137.